Keep Up to Date: Discover the KDIGO 2024 Guidelines for CKD Management!

KDIGO 2024 recommendations for management of CKD

Recommend starting RASi (ACEi or ARB) for people with CKD and severely increased albuminuria (G1–G4, A3) without diabetes

Abbreviations ▼

ACEi: Angiotensin-converting enzyme inhibitor; ARB: Angiotensin II receptor blocker; CKD: Chronic kidney disease; DRI: Direct renin inhibitor; eGFR: Estimated glomerular filtration rate; G: glomerular filtration rate and A: Albuminuria; KDIGO: Kidney disease: Improving global outcomes; NOACs: Non–vitamin K antagonist oral anticoagulants; RASi: Renin-angiotensin system inhibitor; SGLT2i: Sodium-glucose cotransporter-2 inhibitor; T2D: Type 2 diabetes.

References ▼

Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117–S314.

LMRC Code: GGI-CO-A1-AQS-300030873-BANNERS-I24-1528

Disclaimer: For the use of a Registered Medical Practitioner, Hospital or Laboratory only.

The images are for illustrative representation only and do not depict actual medical products, procedures, or outcomes. Refer to official medical guidance and product information for accurate details.

All content including: text, images, audio, or other formats were created for medical educational purposes only. Offerings for continuing education are clearly identified and the appropriate target audience is identified. This communication is restricted for the use of HCPs and must not be shared in public domain. The opinions expressed in this video are solely the views of the speaker. The presentation may contain off label usage of drug(s) aimed at educational purpose only. Dr. Reddy’s Laboratories Ltd including but not limited its Affiliates strictly does not recommend any off label usage of its marketing products. Prior to treatment kindly refer to the latest prescribing information approved by the local authorities. No part of this content may be used, reproduced, transmitted or stored in any form without the written permission of Dr. Reddy’s.

Keep Up to Date: Discover the KDIGO 2024 Guidelines for CKD Management!

Related Articles

Login to continue